Primary Image

Generic Background Image

Clinical Trial

Focus Group: Care Partners of People with SCI

IRB Protocol Number STU00220806

Contact

Lorie Cashdollar lcashdolla@sralab.org

Objective

Are you a care partner of someone with a spinal cord injury? 

Researchers at Shirley Ryan AbilityLab are recruiting for a virtual focus group to find out more about rehabilitation services and outcomes after spinal cord injury. The focus group is part of a research study that aims to expand knowledge about the experiences and outcomes of people living with spinal cord injuries, and how they are related to the length and intensity of rehabilitation services across countries based on findings from research. The purpose of the focus group is to learn how rehabilitation experiences and outcomes are related to rehabilitation length of stay across different countries.

Principal Investigator: Dr. Allen Heinemann, PhD (STU00220806).

Focus group participants will be asked to:

  • Attend one 90-minute online focus group with 4-9 other people
  • Answer questions in a group format about your experience as a care partner of someone with a spinal cord injury
  • Answer survey questions before and after the focus group

Who Can Participate

Eligibility Criteria

  • Providing care for an individual living with a traumatic or nontraumatic spinal cord injury
  • SCI partner is 1+ years post-discharge from inpatient rehabilitation
  • At least 18 years old
  • Able to participate in the online focus group
  • Able to provide consent

Compensation

Participants will receive $25.

Age Range

18+

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan AbilityLab. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all